| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/16/2006 | WO2006027468A2 Hla-dp4 restricted t cd4+ du vih epitopes and the use thereof |
| 03/16/2006 | WO2006027374A1 Identification of feline or canine probnp |
| 03/16/2006 | WO2006027222A1 Electrical connector for a test strip |
| 03/16/2006 | WO2006027147A2 Diagnostics and therapeutics for diseases associated with adrenomedullin receptor (amdr) |
| 03/16/2006 | WO2006027117A2 Diagnostics and therapeutics for diseases associated with cysteinyl leukotriene receptor 2 (cyslt2) |
| 03/16/2006 | WO2006027088A1 Method for increasing the dynamic recording range for microarrays |
| 03/16/2006 | WO2006026994A1 Crystal structure of house dust mite allergen der p 1 |
| 03/16/2006 | WO2006014638A3 ANTIBODIES TO CROSS-LINKED AMYLOID β OLIGOMERS |
| 03/16/2006 | WO2006003414A3 Biomarkers of alzheimer's disease |
| 03/16/2006 | WO2005118813A3 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein |
| 03/16/2006 | WO2005117538A9 METHODS AND COMPOSITIONS FOR INHIBITING ABAD/Aβ PROTEIN INTERACTION |
| 03/16/2006 | WO2005116645A3 Isolation of allergen-specific immunoglobulin genes from human b-cells from atopy sufferers |
| 03/16/2006 | WO2005114215A3 Method of improving t cell receptors |
| 03/16/2006 | WO2005112742A3 Diagnostic test strip for collecting and detecting an analyte in a fluid sample and method for using same |
| 03/16/2006 | WO2005111625A3 Method to predict prostate cancer |
| 03/16/2006 | WO2005111605A3 Biomarkers for the prediction and treatment of drug-induced diarrhoea |
| 03/16/2006 | WO2005108998A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor beta-3 adreno (adrb3) |
| 03/16/2006 | WO2005108995A3 Compositions, test kits and methods for detecting helicobacter pylori |
| 03/16/2006 | WO2005106488A3 Diagnostics and therapeutics for diseases associated with g protein-coupled beta-2 adrenoceptor (adrb2) |
| 03/16/2006 | WO2005106468A3 Clamp-on chamber for flow porometry |
| 03/16/2006 | WO2005105847A3 Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof |
| 03/16/2006 | WO2005103232A3 Isolation and culture of a high purity population of cone photoreceptor cells by tissue dissociation and pna-panning, and biological applications thereof |
| 03/16/2006 | WO2005101011A3 Diagnostics and therapeutics for diseases associated with lxr-alpha (lxra) |
| 03/16/2006 | WO2005100553A3 Method for assessment of cytotoxic lymphocyte activity |
| 03/16/2006 | WO2005095984A3 Diagnostics and therapeutics for diseases associated with g protein-coupled alpha 2a-adrenoceptor (adra2a) |
| 03/16/2006 | WO2005090994A3 Diagnostics and therapeutics for diseases associated with protein kinase, cgmp-dependent, type i (prkg1) |
| 03/16/2006 | WO2005083440A3 Identification of cancer protein biomarkers using proteomic techniques |
| 03/16/2006 | WO2005081721A3 Method for enhancing transport of semiconductor nanocrystals across biological membranes |
| 03/16/2006 | WO2005077007A3 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 03/16/2006 | WO2005070148A3 Methods of using high affinity atiii variants |
| 03/16/2006 | WO2005070122A3 Mechanosensitive ion channels and methods of use |
| 03/16/2006 | WO2005069852A3 Primary central nervous system tumor specific behab isoforms |
| 03/16/2006 | WO2005063817A3 Methods for identifying functional antibodies |
| 03/16/2006 | WO2005063815A3 Fcϝ receptor-binding polypeptide variants and methods related thereto |
| 03/16/2006 | WO2005063745A3 Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof |
| 03/16/2006 | WO2005061736A3 Sleep genes in drosophila and their use for the screening, diagnosis and therapy of sleep disorders |
| 03/16/2006 | WO2005019795A3 Electrochemical sensors including electrode systems with increased oxygen generation |
| 03/16/2006 | WO2005007119A3 Assays for protease enzyme activity |
| 03/16/2006 | WO2004092342A3 Lateral flow system for nucleic acid detection |
| 03/16/2006 | WO2004090102A3 Prion protein binding materials and methods of use |
| 03/16/2006 | WO2004016733A3 Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
| 03/16/2006 | WO2003076333A3 Crystalline structure of human mapkap kinase-2 |
| 03/16/2006 | US20060059579 Model animals non-responsive to mycobacteria-origin lipoprotein/lipopeptide |
| 03/16/2006 | US20060058988 Method and apparatus for computer modeling a joint |
| 03/16/2006 | US20060058967 Method of designing probe set, microarray having substrate on which probe designed by the method is immobilized, and computer readable medium on which program for executing the method is recorded |
| 03/16/2006 | US20060058904 Method and system for concrete quality control based on the concrete's maturity |
| 03/16/2006 | US20060058697 Portable health check apparatus and expiration analysis service method using the same |
| 03/16/2006 | US20060058694 Electrodynamic sensors and applications thereof |
| 03/16/2006 | US20060058516 Novel serine-threonine kinase |
| 03/16/2006 | US20060058510 Lipocalins having a cylindrical beta-pleated sheet of eight beta -strands connected pair-wise by four peptide loops to define a bindingpocket; sequences of bilin-binding protein of Pieris brassicae; genetic engineering; mutants; small chemical, peptide epitopes with determinable affinity >105 M-1 |
| 03/16/2006 | US20060058505 Nucleic acid and polypeptide linked to breast cancer and uses therefor |
| 03/16/2006 | US20060058504 Peptides capable of inducing attraction to the axonal growth and their use for treating neurodegenerative diseases |
| 03/16/2006 | US20060058369 Therapeutic methods employing PAI-1 inhibitors and transgenic non-human animal for screening candidate PAI-1 inhibitors |
| 03/16/2006 | US20060058228 nine amino acid, disulfide-constrained peptide that selectively bound and was internalized into colon cancer cells; exhibit decreased or a substantially nonexistent immunogenicity in an in vivo system |
| 03/16/2006 | US20060058227 Hedgehog-related prophylaxis, therapy and diagnosis of gi tract carcinogenesis |
| 03/16/2006 | US20060058225 Used of inhibitors of phospholipase a2 for the treatment, prevention or diagnosis of neural inflammatory or demyelinating disease |
| 03/16/2006 | US20060057741 Detecting preferential drug in sample; obtain antigens, immobilize to solid support, incubate with sample and colorigenic substrate, detect signal; marijuana, cocaine, methamphetamine, methyltestosterone, or mesterolone |
| 03/16/2006 | US20060057740 Method for manufacturing tool for analysis |
| 03/16/2006 | US20060057739 Method of identification and quantification of proteins, isoforms of the angiotensin i converting enzyme |
| 03/16/2006 | US20060057735 Test piece for protein assay and process for producing the same |
| 03/16/2006 | US20060057734 Preformulation analysis and optimization |
| 03/16/2006 | US20060057732 Methods in the diagnosis of pulmonary embolism |
| 03/16/2006 | US20060057731 Method for analyzing c-terminal amono acid sequence of peptide |
| 03/16/2006 | US20060057730 Method for protein determination, indicator for protein determination, and test piece for protein determination |
| 03/16/2006 | US20060057727 System for monitoring the health of electrical generators and method thereof |
| 03/16/2006 | US20060057721 Identifying agents which modulate cell death, indicated by the expression of caspase-2 and/or caspase-7, in Glial cell line-derived neurotrophic factor (GDNF) family growth factor deprived neuronal or nonneuronal cells |
| 03/16/2006 | US20060057720 Mesenchymal cells derived from human embryonic stem cells |
| 03/16/2006 | US20060057707 High-throughput instrument for high sensitivity assays without any type of label in a format that is readily compatible with the microtiter plate-based or microarray-based infrastructureoften used for biomolecular interaction analysis; optical grating having a high refractive index; immobilization |
| 03/16/2006 | US20060057703 Method for the evaluation of implantable materials |
| 03/16/2006 | US20060057694 Rat receptor tyrosine knase, kdr |
| 03/16/2006 | US20060057663 Novel g protein-coupled receptor protein and dna thereof |
| 03/16/2006 | US20060057662 Membrane scaffold proteins |
| 03/16/2006 | US20060057659 Destructible surfactants and uses thereof |
| 03/16/2006 | US20060057656 Busulfan immunoassay |
| 03/16/2006 | US20060057655 obtaining a fraction containing one or more irradiation-generated fragments of natural high-molecular weight compound(s) from a food sample, reacting the fraction with antibodies capable of recognizing the fragments, thereby detecting the one or more fragments; fractionation |
| 03/16/2006 | US20060057654 Methods for determining susceptibility to dental caries |
| 03/16/2006 | US20060057653 Detection of microorganisms with holographic sensors |
| 03/16/2006 | US20060057652 Methods for identifying therapeutic agents and for treating disease |
| 03/16/2006 | US20060057651 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 03/16/2006 | US20060057650 Enriching tumor cells from a body fluid, in which a cell separation medium of a specific density is overlaid with the body fluid and it is subsequently determined whether the enriched cells express an epithelial marker, for example a cytokeratin |
| 03/16/2006 | US20060057649 Screening method and anti-tumor drug candidate obtained therefrom |
| 03/16/2006 | US20060057648 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 03/16/2006 | US20060057647 Detection and identification of saxiphilins using saxitoxin-biotin conjugates |
| 03/16/2006 | US20060057646 Diagnosis of Alzheimer's disease |
| 03/16/2006 | US20060057645 Novel genes |
| 03/16/2006 | US20060057644 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 03/16/2006 | US20060057643 Methods and compositions for detecting erythrovirus genotypes |
| 03/16/2006 | US20060057642 Determining the level of monomeric C-reactive protein (mCRP) in the sample and comparing the level of mCRP in the sample with predetermined value |
| 03/16/2006 | US20060057641 Having T cell stimulatory activity of a dog dander allergen, therapy |
| 03/16/2006 | US20060057640 Using receptor tyrosine phosphatases as tools in identifying modulators for prevention and treatment of nervous system, cell proliferative and respiratory system disorders |
| 03/16/2006 | US20060057639 CaMKII/calcium channel phosphorylation-related compositions and methods |
| 03/16/2006 | US20060057638 Methods and products related to the improved analysis of carbohydrates |
| 03/16/2006 | US20060057637 for detection of preferential biological targets; inorganic particle such as semiconductor ZnSe and Ag, Au or phosphor as colloid, distal end of dimercaptooctanoic acid/6,8-/ bound to outer surface of inorgaic particle, macromolecule (polypeptide) electrostatically bound with particles; self-assembly |
| 03/16/2006 | US20060057636 Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins |
| 03/16/2006 | US20060057635 Coated metal surface on solid support for displacement reactions |
| 03/16/2006 | US20060057634 Assay for glycosylated proteins |
| 03/16/2006 | US20060057632 Artificial antibody library with super-repertory |
| 03/16/2006 | US20060057631 Nano-structured device for analysis or separation, and its preparation and application |
| 03/16/2006 | US20060057628 Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof |
| 03/16/2006 | US20060057623 SENP1 as a marker of cancer development and target for cancer therapy |